BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 36617779)

  • 1. TDP-43 Pathology in the Setting of Intermediate and High Alzheimer's Disease Neuropathologic Changes: A Preliminary Evaluation Across Ethnoracial Groups.
    Huie EZ; Escudero A; Saito N; Harvey D; Nguyen ML; Lucot KL; LaGrande J; Mungas D; DeCarli C; Lamar M; Schneider JA; Kapasi A; Rissman RA; Teich AF; Dugger BN
    J Alzheimers Dis; 2023; 91(4):1291-1301. PubMed ID: 36617779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethnoracial differences in Alzheimer's disease from the FLorida Autopsied Multi-Ethnic (FLAME) cohort.
    Santos OA; Pedraza O; Lucas JA; Duara R; Greig-Custo MT; Hanna Al-Shaikh FS; Liesinger AM; Bieniek KF; Hinkle KM; Lesser ER; Crook JE; Carrasquillo MM; Ross OA; Ertekin-Taner N; Graff-Radford NR; Dickson DW; Murray ME
    Alzheimers Dement; 2019 May; 15(5):635-643. PubMed ID: 30792090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropathological Diagnoses of Demented Hispanic, Black, and Non-Hispanic White Decedents Seen at an Alzheimer's Disease Center.
    Filshtein TJ; Dugger BN; Jin LW; Olichney JM; Farias ST; Carvajal-Carmona L; Lott P; Mungas D; Reed B; Beckett LA; DeCarli C
    J Alzheimers Dis; 2019; 68(1):145-158. PubMed ID: 30775996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethnoracial differences in the clinical characteristics of Alzheimer's disease at initial presentation at an urban Alzheimer's disease center.
    Livney MG; Clark CM; Karlawish JH; Cartmell S; Negrón M; Nuñez J; Xie SX; Entenza-Cabrera F; Vega IE; Arnold SE
    Am J Geriatr Psychiatry; 2011 May; 19(5):430-9. PubMed ID: 21522051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rates of dementia in three ethnoracial groups.
    Gurland BJ; Wilder DE; Lantigua R; Stern Y; Chen J; Killeffer EH; Mayeux R
    Int J Geriatr Psychiatry; 1999 Jun; 14(6):481-93. PubMed ID: 10398359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TDP-43 stage, mixed pathologies, and clinical Alzheimer's-type dementia.
    James BD; Wilson RS; Boyle PA; Trojanowski JQ; Bennett DA; Schneider JA
    Brain; 2016 Nov; 139(11):2983-2993. PubMed ID: 27694152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rates of hippocampal atrophy and presence of post-mortem TDP-43 in patients with Alzheimer's disease: a longitudinal retrospective study.
    Josephs KA; Dickson DW; Tosakulwong N; Weigand SD; Murray ME; Petrucelli L; Liesinger AM; Senjem ML; Spychalla AJ; Knopman DS; Parisi JE; Petersen RC; Jack CR; Whitwell JL
    Lancet Neurol; 2017 Nov; 16(11):917-924. PubMed ID: 28919059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Clinical, Genetic, and Pathologic Features of Limbic and Diffuse Transactive Response DNA-Binding Protein 43 Pathology in Alzheimer's Disease Neuropathologic Spectrum.
    Carlos AF; Machulda MM; Rutledge MH; Nguyen AT; Reichard RR; Baker MC; Rademakers R; Dickson DW; Petersen RC; Josephs KA
    J Alzheimers Dis; 2023; 93(4):1521-1535. PubMed ID: 37182869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TDP-43 and Alzheimer's Disease Pathologic Subtype in Non-Amnestic Alzheimer's Disease Dementia.
    Sahoo A; Bejanin A; Murray ME; Tosakulwong N; Weigand SD; Serie AM; Senjem ML; Machulda MM; Parisi JE; Boeve BF; Knopman DS; Petersen RC; Dickson DW; Whitwell JL; Josephs KA
    J Alzheimers Dis; 2018; 64(4):1227-1233. PubMed ID: 30010126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TDP-43 pathology in anterior temporal pole cortex in aging and Alzheimer's disease.
    Nag S; Yu L; Boyle PA; Leurgans SE; Bennett DA; Schneider JA
    Acta Neuropathol Commun; 2018 May; 6(1):33. PubMed ID: 29716643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of mild cognitive impairment among older adults in the United States by ethnoracial group.
    Perales-Puchalt J; Gauthreaux K; Shaw A; McGee JL; Teylan MA; Chan KCG; Rascovsky K; Kukull WA; Vidoni ED
    Int Psychogeriatr; 2021 Jan; 33(1):51-62. PubMed ID: 31948505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ethnoracial sleep disparities among college students living in dormitories in the United States: a nationally representative study.
    Jones RD; Jackson WB; Mazzei A; Chang AM; Buxton OM; Jackson CL
    Sleep Health; 2020 Feb; 6(1):40-47. PubMed ID: 31759933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Race/ethnic differences in AD survival in US Alzheimer's Disease Centers.
    Mehta KM; Yaffe K; Pérez-Stable EJ; Stewart A; Barnes D; Kurland BF; Miller BL
    Neurology; 2008 Apr; 70(14):1163-70. PubMed ID: 18003939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dichotomous scoring of TDP-43 proteinopathy from specific brain regions in 27 academic research centers: associations with Alzheimer's disease and cerebrovascular disease pathologies.
    Katsumata Y; Fardo DW; Kukull WA; Nelson PT
    Acta Neuropathol Commun; 2018 Dec; 6(1):142. PubMed ID: 30567576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TDP-43 pathology in Alzheimer's disease, dementia with Lewy bodies and ageing.
    McAleese KE; Walker L; Erskine D; Thomas AJ; McKeith IG; Attems J
    Brain Pathol; 2017 Jul; 27(4):472-479. PubMed ID: 27495267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TAR DNA-binding protein 43 and pathological subtype of Alzheimer's disease impact clinical features.
    Josephs KA; Whitwell JL; Tosakulwong N; Weigand SD; Murray ME; Liesinger AM; Petrucelli L; Senjem ML; Ivnik RJ; Parisi JE; Petersen RC; Dickson DW
    Ann Neurol; 2015 Nov; 78(5):697-709. PubMed ID: 26224156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein contributions to brain atrophy acceleration in Alzheimer's disease and primary age-related tauopathy.
    Josephs KA; Martin PR; Weigand SD; Tosakulwong N; Buciuc M; Murray ME; Petrucelli L; Senjem ML; Spychalla AJ; Knopman DS; Boeve BF; Petersen RC; Parisi JE; Dickson DW; Jack CR; Whitwell JL
    Brain; 2020 Dec; 143(11):3463-3476. PubMed ID: 33150361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TAR DNA-binding protein 43 pathology in Alzheimer's disease with psychosis.
    Vatsavayi AV; Kofler J; Demichele-Sweet MA; Murray PS; Lopez OL; Sweet RA
    Int Psychogeriatr; 2014 Jun; 26(6):987-94. PubMed ID: 24588894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MRI-based basal forebrain atrophy and volumetric signatures associated with limbic TDP-43 compared to Alzheimer's disease pathology.
    Teipel S; Grothe MJ;
    Neurobiol Dis; 2023 May; 180():106070. PubMed ID: 36898615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TDP-43 pathological changes in early onset familial and sporadic Alzheimer's disease, late onset Alzheimer's disease and Down's syndrome: association with age, hippocampal sclerosis and clinical phenotype.
    Davidson YS; Raby S; Foulds PG; Robinson A; Thompson JC; Sikkink S; Yusuf I; Amin H; DuPlessis D; Troakes C; Al-Sarraj S; Sloan C; Esiri MM; Prasher VP; Allsop D; Neary D; Pickering-Brown SM; Snowden JS; Mann DM
    Acta Neuropathol; 2011 Dec; 122(6):703-13. PubMed ID: 21968532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.